Warning: The NCBI web site requires JavaScript to function. more...
Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.
Seismann H, Blank S, Cifuentes L, Braren I, Bredehorst R, Grunwald T, Ollert M, Spillner E.
Clin Mol Allergy. 2010 Apr 1;8:7.
Related citations
Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
Blank S, Seismann H, Bockisch B, Braren I, Cifuentes L, McIntyre M, Rühl D, Ring J, Bredehorst R, Ollert MW, Grunwald T, Spillner E.
J Immunol. 2010 May 1;184(9):5403-13. Epub 2010 Mar 26.
Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of alpha-1,3-core fucosylation.
Seismann H, Blank S, Braren I, Greunke K, Cifuentes L, Grunwald T, Bredehorst R, Ollert M, Spillner E.
Mol Immunol. 2010 Jan;47(4):799-808. Epub 2009 Nov 6.
Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.
Mittermann I, Zidarn M, Silar M, Markovic-Housley Z, Aberer W, Korosec P, Kosnik M, Valenta R.
J Allergy Clin Immunol. 2010 Jun;125(6):1300-1307.e3. Epub 2010 May 13.
Selection of Hymenoptera venoms for immunotherapy on the basis of patient's IgE antibody cross-reactivity.
Hamilton RG, Wisenauer JA, Golden DB, Valentine MD, Adkinson NF Jr.
J Allergy Clin Immunol. 1993 Nov;92(5):651-9.
Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cells.
Blank S, Michel Y, Seismann H, Plum M, Greunke K, Grunwald T, Bredehorst R, Ollert M, Braren I, Spillner E.
Protein Pept Lett. 2011 Apr;18(4):415-22.
Identification by immunoblot of venom glycoproteins displaying immunoglobulin E-binding N-glycans as cross-reactive allergens in honeybee and yellow jacket venom.
Hemmer W, Focke M, Kolarich D, Dalik I, Götz M, Jarisch R.
Clin Exp Allergy. 2004 Mar;34(3):460-9.
Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
Müller UR, Johansen N, Petersen AB, Fromberg-Nielsen J, Haeberli G.
Allergy. 2009 Apr;64(4):543-8. Epub 2008 Dec 18.
Allergens in hymenoptera venom. V. Identification of some of the enzymes and demonstration of multiple allergens in yellow jacket venom.
Hoffman DR.
Ann Allergy. 1978 Mar;40(3):171-6.
Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
Winkler B, Bolwig C, Seppälä U, Spangfort MD, Ebner C, Wiedermann U.
Immunology. 2003 Nov;110(3):376-85.
Diagnosis of Hymenoptera venom allergy.
Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN; EAACI Interest Group on Insect Venom Hypersensitivity.
Allergy. 2005 Nov;60(11):1339-49. Review.
Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts.
Blank S, Seismann H, Michel Y, McIntyre M, Cifuentes L, Braren I, Grunwald T, Darsow U, Ring J, Bredehorst R, Ollert M, Spillner E.
Allergy. 2011 Oct;66(10):1322-9. doi: 10.1111/j.1398-9995.2011.02667.x. Epub 2011 Jun 10.
In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition.
Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hübsch-Müller C, Enk A.
Allergy. 2006 Oct;61(10):1220-9.
Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.
Scherer K, Weber JM, Jermann TM, Krautheim A, Tas E, Ueberschlag EV, Cammarata M, Bircher AJ.
Int Arch Allergy Immunol. 2008;146(2):122-32. Epub 2008 Jan 18.
Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG.
Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):323-9. Review.
Hypersensitivity to Hymenoptera venom: advances in diagnosis and implications for treatment.
Incorvaia C, Mauro M, Pravettoni V, Pucci S.
Recent Pat Inflamm Allergy Drug Discov. 2011 May;5(2):128-35. Review.
Reassessing the role of hyaluronidase in yellow jacket venom allergy.
Jin C, Focke M, Léonard R, Jarisch R, Altmann F, Hemmer W.
J Allergy Clin Immunol. 2010 Jan;125(1):184-90.e1. Epub 2009 Nov 11.
Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition.
Seppälä U, Selby D, Monsalve R, King TP, Ebner C, Roepstorff P, Bohle B.
Mol Immunol. 2009 Jun;46(10):2014-21. Epub 2009 Apr 16.
Major venom allergen of yellow jackets, Ves v 5: structural characterization of a pathogenesis-related protein superfamily.
Henriksen A, King TP, Mirza O, Monsalve RI, Meno K, Ipsen H, Larsen JN, Gajhede M, Spangfort MD.
Proteins. 2001 Dec 1;45(4):438-48.
Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
Kochuyt AM, Van Hoeyveld EM, Stevens EA.
Clin Exp Allergy. 2005 Apr;35(4):441-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on